Dose Form Intended Site

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

Overview

736479009 |Dose form intended site (intended site)| represents a general type of site of administration (e.g. cutaneous, nasal, oral, parenteral). This subhierarchy is a descendant of 362981000 |Qualifier value (qualifier value)| that supports fully defining the 736542009 |Pharmaceutical dose form (dose form)| hierarchy. |Dose form intended site (intended site)| is used to model concepts in the |Pharmaceutical dose form (dose form)| hierarchy; they are not used to model 763158003 |Medicinal product (product)|.

|Dose form intended site| should not be confused with route of administration , which is a concept used in dosage instructions for the administration of a particular medicinal product to a particular patient.

Modeling

Parent concept

<<736479009 |Dose form intended site (intended site)

Semantic tag

(intended site)

Definition status

Primitive

Attributes

None

Naming

FSN

Use the following pattern for the FSN where X is the intended site:

X (intended site)

For example,

  • Oral (intended site)

  • Otic (intended site)

  • Parenteral (intended site)

  • Vaginal (intended site)

Preferred Term

Use the following pattern for the PT where X is the intended site:

X

For example,

  • Oral

  • Otic

  • Parenteral

  • Vaginal

Synonym

Synonyms are not allowed unless explicitly identified as an exception in the Editorial Guidelines.

Text Definitions

Preferred; not required.

Exemplars

Provide Feedback

Last updated